Management Change: Chief Financial Officer of Ortho Clinical Diagnostics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Jefferies Remains Bullish in the Wake of Bruker's (BRKR) Surprise CFO Departure
May 21, 2015 7:50 AM EDTJefferies maintains a Buy rating and $25 price target on Bruker (NASDAQ: BRKR) following the surprise departure of CFO, Charlie Wagner. It was announced last night that Wagner will be stepping down as CFO next month to join Ortho-Clinical Diagnostics (OCD) as CFO. Analyst Brandon Couillard believes that the departure will have a negative psychological impact... More
William Blair Downgrades Bruker (BRKR) to Market Perform
May 21, 2015 6:43 AM EDTWilliam Blair downgraded Bruker (NASDAQ: BRKR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.
Shares of Bruker closed at $22.21 yesterday.
... MoreBruker (BRKR) CFO Wagner to Resign
May 20, 2015 4:10 PM EDTBruker Corporation (NASDAQ: BRKR) announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO) of Bruker since July 2012, submitted his resignation, effective June 12, 2015, in order to pursue other interests. Mr. Wagner has informed the Company that he has accepted a position as Chief Financial Officer of Ortho-Clinical Diagnostics, Inc., and will commence service in that position in late June 2015. Mr. Wagners resignation is not the result of any dispute or disagreement with the Company or any matter relating to the Companys accounting practices or financial... More
